Abstract | AIMS: MAIN METHODS: A rat model of cholestasis induced by bile duct ligation (BDL) was used for the study. The detection of iron and the expression of relevant molecules were performed one week after surgery in the control, and cholestatic animals after treatment with either saline or pravastatin (1mg/kg/day). KEY FINDINGS: SIGNIFICANCE:
Cholestasis-induced increase in plasma and decrease in hepatic iron levels were associated with up-regulation of liver HO-1 and ferroportin 1. Pravastatin alleviated cholestatic liver impairment and raised liver iron content by modulation of heme catabolism and an increase of hepatic iron uptake and storage capacity.
|
Authors | Gabriela Kolouchova, Eva Brcakova, Petra Hirsova, Jolana Cermanova, Leos Fuksa, Jaroslav Mokry, Petr Nachtigal, Hana Lastuvkova, Stanislav Micuda |
Journal | Life sciences
(Life Sci)
Vol. 89
Issue 19-20
Pg. 717-24
(Nov 07 2011)
ISSN: 1879-0631 [Electronic] Netherlands |
PMID | 21925516
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2011 Elsevier Inc. All rights reserved. |
Chemical References |
- Antimicrobial Cationic Peptides
- Cation Transport Proteins
- Hamp protein, rat
- Hepcidins
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- metal transporting protein 1
- Iron
- Heme Oxygenase-1
- Pravastatin
|
Topics |
- Animals
- Antimicrobial Cationic Peptides
(genetics)
- Cation Transport Proteins
(genetics)
- Cholestasis
(drug therapy, physiopathology)
- Disease Models, Animal
- Gene Expression Regulation
(drug effects)
- Heme Oxygenase-1
(metabolism)
- Hepcidins
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
(pharmacology)
- Iron
(metabolism)
- Liver
(drug effects, metabolism)
- Male
- Pravastatin
(pharmacology)
- Rats
- Rats, Wistar
|